https://www.taxtmi.com/news?id=52145 Remedium Lifecare recorded a substantial profitability turnaround in Q1 FY26, posting Positive Profit After Tax that exceeds the entire prior fiscal year's profit and reverses the preceding quarter's loss, driven by higher revenue, improved cost management and stronger operational efficiency. The company plans to expand R&D across key therapeutic areas, build CDMO and R&D services with backward integration to improve margins, strengthen working capital, and pursue selective international market entry to sustain growth and consolidate its supply-chain position. en-us Mon, 11 Aug 2025 16:16:03 +0530 Mon, 11 Aug 2025 16:16:03 +0530 TaxTMI RSS Generator https://www.taxtmi.com/news?id=52145 Remedium Lifecare recorded a substantial profitability turnaround in Q1 FY26, posting Positive Profit After Tax that exceeds the entire prior fiscal year's profit and reverses the preceding quarter's loss, driven by higher revenue, improved cost management and stronger operational efficiency. The company plans to expand R&D across key therapeutic areas, build CDMO and R&D services with backward integration to improve margins, strengthen working capital, and pursue selective international market entry to sustain growth and consolidate its supply-chain position. News - Mon, 11 Aug 2025 16:16:03 +0530 https://www.taxtmi.com/news?id=52145